Vats V, Yadav S P, Grover J K
Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110049, India.
J Ethnopharmacol. 2004 Jan;90(1):155-60. doi: 10.1016/j.jep.2003.09.034.
Ocimum sanctum (OS) has been mentioned in Indian system of traditional medicine to be of value in the treatment of diabetes mellitus. We have previously shown that OS shows a dose-dependent hypoglycemic effect and prevented rise in plasma glucose in normal rats. It also showed significant antihyperglycemic effect in STZ-induced diabetes. The present study was undertaken to assess the effect of OS on three important enzymes of carbohydrate metabolism [glucokinase (GK) (EC 2.7.1.2), hexokinase (HK) (EC 2.7.1.1) and phosphofructokinase (PFK) (EC 2.7.1.11)] along with glycogen content of insulin-dependent (skeletal muscle and liver) and insulin-independent tissues (kidneys and brain) in STZ (65 mg/kg) induced model of diabetes for 30 days. Administration of OS extract 200mg/kg for 30 days led to decrease in plasma glucose levels by approximately 9.06 and 26.4% on 15th and 30th day of the experiment. Liver and two-kidney weight expressed as percentage of body weight significantly increased in diabetics (P<0.0005) versus normal controls. OS significantly decreased renal (P<0.0005) but not liver weight. Renal glycogen content increased by over 10 folds while hepatic and skeletal muscle glycogen content decreased by 75 and 68% in diabetic controls versus controls. OS did not affect glycogen content in any tissue. Activity of HK, GK and PFK in diabetic controls was 35, 50 and 60% of the controls and OS partially corrected this alteration.
印度传统医学体系中提到,神圣罗勒(OS)对糖尿病治疗具有价值。我们之前已经表明,OS在正常大鼠中呈现剂量依赖性降血糖作用,并能防止血糖升高。它在链脲佐菌素诱导的糖尿病中也显示出显著的降血糖作用。本研究旨在评估OS对碳水化合物代谢的三种重要酶[葡萄糖激酶(GK)(EC 2.7.1.2)、己糖激酶(HK)(EC 2.7.1.1)和磷酸果糖激酶(PFK)(EC 2.7.1.11)]的影响,以及在链脲佐菌素(65mg/kg)诱导的糖尿病模型中30天,对胰岛素依赖组织(骨骼肌和肝脏)和胰岛素非依赖组织(肾脏和大脑)糖原含量的影响。给予OS提取物200mg/kg,持续30天,在实验的第15天和第30天,血糖水平分别降低了约9.06%和26.4%。与正常对照组相比,糖尿病组肝脏和双肾重量占体重的百分比显著增加(P<0.0005)。OS显著降低了肾脏重量(P<0.0005),但对肝脏重量无影响。与对照组相比,糖尿病对照组肾糖原含量增加了10倍以上,而肝糖原和骨骼肌糖原含量分别降低了75%和68%。OS对任何组织的糖原含量均无影响。糖尿病对照组中HK、GK和PFK的活性分别为对照组的35%、50%和60%,OS部分纠正了这种变化。